# FDA 483 - Pharmatech Inc. - August 09, 2023

Source: https://www.globalkeysolutions.net/records/483/pharmatech-inc/ef49101e-411f-4feb-8f2d-7bfe068d1dca

> FDA 483 for Pharmatech Inc. on August 09, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Pharmatech Inc.
- Inspection Date: 2023-08-09
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Pharmatech Inc. in Lindon, UT, revealed significant deficiencies in the manufacturing and quality control processes for both acidified foods and dietary supplements. Observations included failures to file scheduled processes for new acidified foods, inadequate testing for dietary ingredient identity, incomplete certificates of analysis, and a lack of established contamination limits for finished dietary supplements.

## Related Documents

- [483 - 2018-08-03](https://www.globalkeysolutions.net/records/483/pharmatech-inc/ccdb71db-5347-4309-b958-5fd743f37700)

## Related Officers

- [Douglas J. Snyder](https://www.globalkeysolutions.net/people/douglas-j-snyder/d4fcec9d-230d-4481-a5e5-8ef7d0dbfdd2)

Company: https://www.globalkeysolutions.net/companies/pharmatech-inc/b79566e2-f2fc-4a4a-bf54-6776358ee8aa

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face